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Abstract
Youth with rheumatologic diseases have a high prevalence of comorbid mental health disorders. Individuals with
comorbid mental health disorders are at increased risk for adverse outcomes related to mental health as well as their
underlying rheumatologic disease. Early identification and treatment of mental health disorders has been shown to
improve outcomes, but current systems of care fall short in providing adequate mental health services to those in need.
Pediatric rheumatologists are uniquely positioned to provide mental health screening and intervention for youth with
rheumatologic diseases due to the frequency of patient encounters and ongoing therapeutic relationship with patients
and families. However, additional training is likely required for pediatric rheumatologists to provide effective mental
health care, and focusing efforts on providing trainees with mental health education is key to building competency.
Potential opportunities for improved mental health education include development of clinical guidelines regarding
mental health screening and management within pediatric rheumatology settings and incorporation of mental health
didactics, workshops, and interdisciplinary clinic experiences into pediatric rheumatology fellowship curricula. Additional
steps include mental health education for patients and families and focus on system change, targeting integration of
medical and mental health care. Research is needed to better define the scope of the problem, determine effective
strategies for equipping pediatric rheumatologists with skills in mental health intervention, and develop and implement
sustainable systems for delivery of optimal mental health care to youth with rheumatologic diseases.
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Background
Beyond the long-established detrimental impact that
chronic disease has on an individual’s mental health, we
now appreciate that the relationship between chronic
physical disease and mental illness is bidirectional [1].
As such, providers that care for patients with chronic
diseases must consider their patients’ mental health as
both an outcome of the disease they are treating and a
contributor to their patients’ overall health. Understand-
ing the relationship between mental and physical health
is of utmost importance in pediatric populations, in
which both poor physical and mental health outcomes
can affect development and lead to long-lasting conse-
quences. Empowering pediatric rheumatologists to ef-
fectively address mental health disorders should be seen
as an integral part of optimizing the care for youth with
rheumatologic diseases. This review article aims to de-
scribe the burden and impact of mental health disorders
in youth with rheumatologic diseases, assess current
practices, and explore opportunities to improve mental
health care for this population of vulnerable children.
Burden of mental health disorders in youth with
rheumatologic diseases
Children with chronic diseases have a higher prevalence
of mental illness [2–5], and youth with rheumatologic
diseases are no exception. Psychological comorbidity in
pediatric rheumatology has been studied most for juven-
ile idiopathic arthritis (JIA), systemic lupus erythemato-
sus (SLE), and fibromyalgia. Current prevalence
estimates for depression and anxiety among patients
with these diseases in North America, South America,
Europe, and Asia range from 15 to 65% [6–14], with sui-
cidal ideation rates as high as 14–34% [6, 15, 16]. These
prevalences are disproportionately higher than those ob-
served in healthy controls [6, 7, 9, 13, 17], and by some
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measures are higher compared to children with special
health care needs other chronic diseases such as diabetes
and asthma [18–20]. Moreover, recent studies indicate
that individuals with childhood-onset rheumatologic dis-
ease may be at higher risk for mental health disorders
than individuals with adult-onset disease [21, 22].
Discrepancies in reported prevalence of mental health
disorders in this population are potentially due to small
sample sizes with limited generalizability and the varying
use of symptoms, screeners, or diagnosis codes to define
mental health disease. These limitations and the overall
paucity of existing data regarding mental health comorbidi-
ties across pediatric rheumatologic diseases emphasize the
need for further research to describe better the burden of
mental health disorders in this patient population. Large
collaborative studies that draw on diverse demographics of
patients will be important in defining the scope of the
problem and understanding risk factors for mental health
disorders in youth with rheumatologic diseases.
Impact of mental health disorders in youth with
rheumatologic diseases
Preliminary studies show that mental health disorders
adversely impact quality of life, development, and disease
outcomes in youth with rheumatologic diseases. Under-
standing these effects can illuminate strategies to
optimize overall care. In youth with JIA, depression has
been associated with higher disease activity, worse pain,
worse general health, greater functional disability, and
overall lower health related quality of life (HRQL) scores
[8, 23]. In youth with SLE, depression and anxiety have
been associated with higher disease activity and in-
creased medical services use across ambulatory and
acute care settings [9, 24, 25]. However, it is unclear
whether these are causal relationships. Further research
to investigate these relationships and other potential ad-
verse outcomes related to mental health disorders in
pediatric rheumatologic diseases is needed in order to
guide development and assessment of future targeted
interventions.
While the scope of the problem of mental illness in
youth with rheumatologic diseases has yet to be fully in-
vestigated, studies of other pediatric chronic diseases in-
dicate that mental illness can lead to poor outcomes
during childhood [10, 26–29] and can affect develop-
ment and risk of mental illness in adulthood [30–32]. To
our knowledge, no studies have assessed long-term con-
sequences of mental illness specifically in youth with
rheumatologic diseases, but studies of adults with JIA
found worse mental health, lower health-related quality
of life scores, and higher levels of unemployment than in
healthy controls [33, 34].
The impact of mental health disorders on rheumato-
logic diseases has been more robustly studied in adults
than in children. In adults with SLE, depression is cited as
the most significant predictor of poor health-related qual-
ity of life [35, 36], and positive depression screens have
been associated with elevated disease activity scores in
studies from around the globe including South America
and Asia [37–40]. Similarly, comorbid mental health
disorders in patients with rheumatoid arthritis and psori-
atic arthritis have been associated with higher disease ac-
tivity scores and lower likelihood of achieving remission
[41–43]. Furthermore, depression is a risk factor for non-
adherence to chronic medical treatment [44, 45]; and poor
adherence has been associated with increased disease ac-
tivity, increased ambulatory and acute care, and overall
poor prognosis in adults with SLE [46–49].
Fortunately, early recognition and treatment of mental
health disorders improves outcomes. In small, random-
ized controlled trials cognitive behavioral therapy was
found to lower levels of functional disability and re-
ported depressive symptoms in adolescents with fibro-
myalgia [50] and improve quality of life and adaptive
pain cognitions in children with JIA [51]. Recent system-
atic reviews of psychological interventions for pediatric
chronic illness describe programs implemented within
various settings (i.e. community, school, and clinical prac-
tices) that have resulted in consistent improvement of a
variety of clinical outcomes, particularly when subthresh-
old symptoms are recognized and managed [52–54]. In
adults, early identification of depression, including sub-
threshold symptoms, decreases the risk for major depres-
sion and suicide [55, 56], improves social function,
increases productivity, and decreases absenteeism [57, 58].
Specifically, cognitive-behavioral intervention in adults
with SLE has led to significant reduction in the level of de-
pression and anxiety compared to controls and an overall
improvement in quality of life scores [59].
Mental health care gap for youth with
rheumatologic diseases
Given the impact of mental health disorders on health
outcomes and the effectiveness of psychological inter-
ventions, the United States Preventive Services Task
Force and the Canadian Network for Mood and Anxiety
Treatment recommend screening adolescents for de-
pression [60, 61]. The resulting American Academy of
Pediatrics (AAP) Recommendations for Preventive
Pediatric Health Care and the Guidelines for Adolescent
Depression in Primary Care developed from a collabor-
ate initiative in the United States (US) and Canada en-
courage annual depression screening for all adolescents
in primary care settings [62, 63]. However, less than 1%
of clinic visits included depression screening in a sample
from ambulatory pediatric settings across the US be-
tween 2004 and 2013 [64]. Furthermore, in a recent sur-
vey by the AAP nearly 40% of the 512 responding
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pediatricians reported they lacked confidence in their
ability to recognize mental health problems and greater
than 50% reported they lacked confidence in their ability
to treat them. These factors likely contributed to the re-
sponses from 44% of those surveyed who reported they
were not interested in treating, managing, or co-
managing childhood mental health disorders [65].
This situation might be acceptable if access to
pediatric mental health providers were not exceedingly
limited. Workforce data from the American Academy of
Child and Adolescent Psychiatry indicates that there are
approximately 8300 practicing child and adolescent psy-
chiatrists in the US with over 15 million youth in need
of one [66]. Additional data describes that 96% of coun-
ties in the US have an unmet need for prescribing men-
tal health professionals [67], with an uneven distribution
leaving rural and low-income populations underserved
[68]. Similar data has been reported by the Child and
Adolescent Mental Health in Europe project that summa-
rized collective experiences from 15 countries within the
European Union and highlighted specific gaps in provider
education and available preventative services [69].
Thus, the current systems of care fall short in terms of
meeting the mental health needs for youth with rheuma-
tologic diseases. In a survey by the Childhood Arthritis
and Rheumatology Research Alliance (CARRA), which
includes pediatric rheumatologists from both US and
Canada, 52% of surveyed members reported inadequate
symptom identification; and 45% reported inadequate
treatment of depression and anxiety in adolescents with
SLE, identifying limited staff resources and availability of
mental health providers as top barriers to mental health
intervention [70]. These barriers are not exclusive to
pediatric rheumatology settings and have been cited as
barriers to identification and management of psycho-
social problems within general pediatrics settings as well
[65]. Yet, it is notable that only 31% of the 100 CARRA
pediatric rheumatology centers report having an affili-
ated social worker or psychologist. When these providers
were surveyed, 35% reported inadequate connection of
patients to mental health services; and 52% reported in-
adequate follow-up of mental health referrals at their
practice [71].
Value of pediatric rheumatologists for identifying
and addressing mental health disorders
The increased risk of mental health disorders in youth
with rheumatologic diseases and their impact on clinical
and psychosocial outcomes, as well as the shortage of
mental health providers, underscore the need for
pediatric rheumatologists to be proficient in addressing
mental health needs for these vulnerable patients.
Pediatric rheumatologists are optimally positioned to
improve mental health intervention due to the frequency
and intensity of their patient-provider interactions.
Youth with SLE and MCTD have on average twice the
number of rheumatology visits compared to primary
care visits, and one study found youth with SLE and de-
pressive symptoms to have fewer primary care visits than
youth with SLE and no depressive symptoms [6]. Fur-
thermore, in a qualitative interview study, almost all par-
ents of youth with SLE and MCTD said they would feel
comfortable bringing concerns about their child’s mental
health to the rheumatologist; reasons for this included
trust and confidence in the therapeutic relationship with
his/her rheumatologist, whom they viewed as the pri-
mary doctor for their child [72]. In fact, the majority of
patients surveyed in an ongoing mood screening project
for youth with SLE believe that emotional health should
be addressed by their rheumatologist [Rubinstein, un-
published data]. Additionally, a preliminary study of
cognitive-behavioral therapy to improve pain and well-
being in children with JIA indicated that this interven-
tion within the pediatric rheumatology setting was ac-
ceptable to patients and families [51].
Current state of mental health education for
pediatric rheumatologists
To begin closing the mental health care gap for youth
with rheumatologic diseases, pediatric rheumatologists
must feel adept in the screening and initial management
of mental health disorders. Symptoms of mental health
disorders are often subtle and can be easily overlooked
despite multiple interactions between youth with chronic
conditions and the health care system. Thus, pediatric
subspecialists need to learn how to implement formal
screening methods into routine clinical care, effectively
communicate with patients, families, and other providers
regarding mental health, and assist with establishing and
sustaining appropriate mental health intervention.
Current training program requirements outlined by
the Accreditation Council of Graduate Medical Educa-
tion simply call for adequate resources for an education
in mental health and social services [73]. The American
Board of Pediatrics (ABP) provides slightly more detailed
expectations in subspecialty content outlines used to de-
velop questions for board certification examinations. For
pediatric rheumatology, the ABP lists the following three
learning objectives relevant to mental health care:
recognize the cardinal features of depression, determine
when depression requires professional consultation, and
recognize suicide warning signs [74]. The Objectives of
Training in the Subspecialty of Adult and Pediatric
Rheumatology from the Royal College of Physicians and
Surgeons of Canada and the European Union of Medical
Specialists Training Requirements for the Specialty of
Rheumatology do not specifically address training for
management of mental health comorbidities [75, 76].
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Therefore, current training programs likely insuffi-
ciently prepare pediatric rheumatologists to manage
mental health comorbidities in youth with rheumato-
logic disease. In a CARRA survey of 130 pediatric rheu-
matologists, two-thirds reported formal mental health
training only in medical school and nearly 10% reported
no training at all. Importantly, the respondents with
higher levels of mental health training perceived a lower
frequency of barriers to mental health screening, and
greater than 90% of respondents expressed interest in
further mental health training [70]. These data highlight
the potential value that mental health education for
pediatric rheumatologists may have on improving care
for youth with rheumatologic diseases.
Opportunities for improved mental health
education for pediatric rheumatologists
The most basic measure to tackle this educational need
might be to provide guidelines for mental health screening
to pediatric rheumatologists. The American Diabetes Asso-
ciation and the American College of Gastroenterology both
issued 2017 guidelines for standards of medical care in dia-
betes and preventive care in inflammatory bowel disease,
respectively, that include recommendations for routine de-
pression and anxiety screening [77, 78]. Such guidelines,
however, do not exist for rheumatology. While 85% of sur-
veyed CARRA-affiliated pediatric rheumatologists support
routine screening for depression and anxiety in adolescents
with SLE, only 2% of practices report routine screening
with a standardized instrument [70]. Several standardized
and validated instruments exist for mental health screening
in children and adolescents, and many of these instru-
ments are available free of charge and with translations in
multiple languages [79, 80]. Setting a standard of pediatric
rheumatology care inclusive of routine mental health
screening, via guidelines and recommendations from pro-
fessional associations in rheumatology, may be highly valu-
able to educate pediatric rheumatologists about mental
health screening.
For pediatric rheumatology trainees, mental health
education could be delivered in didactics within fellow-
ship core curricula or offered in workshops at academic
conferences. However, mastery of the skills to elicit in-
formation on the symptoms of a mental health disorder
in a patient interview likely requires more intensive in-
struction from behavioral health specialists. Dedicated
rotations in behavioral health clinics could provide this
needed education if protected time for trainees and
mental health providers is secured. Furthermore, train-
ing pediatric rheumatologists in the setting of interdis-
ciplinary clinics, where rheumatology and behavioral
health trainees work side by side, may offer the most
comprehensive opportunity to educate providers and im-
prove mental health care in pediatric rheumatology.
While it potentially involves restructuring the way care
is provided to patients, it has been proven to be effective
for enhancing pediatric resident education in the man-
agement of behavioral health problems and improving
collaboration between pediatricians and behavioral
health specialists [81]. Accordingly, efforts are ongoing
by the ABP to promote longitudinal partnerships be-
tween trainees and behavioral health providers within in-
tegrated ambulatory and inpatient settings [82]. These
types of programs are also viewed by physicians and pa-
tients as a valuable strategy to improve access to mental
health services and ease care coordination for at risk
populations [83], and the approach is endorsed in a 2016
perspectives paper from the National Academy of Medi-
cine [84].
Further research is needed to develop effective educa-
tion programs that will optimize mental health care for
youth with rheumatologic diseases. The National Acad-
emy of Medicine has outlined a research agenda to sup-
port an integrative mental health training paradigm with
attention to the following topics: comparative studies of
different structural configurations of the interface of
pediatric medical care and behavioral health support; de-
velopment of quality indicators that assess competencies
for integrative team training and that lead to improved
health outcomes for children; and study of new integrative
training models for children with chronic disorders [84].
Studies investigating these topics will help determine best
training practices that lead to the greatest impact on men-
tal health for youth with rheumatologic diseases.
Additional steps for improved mental health care
for youth with rheumatologic diseases
Early and ongoing mental health education for patients
and families of youth with rheumatologic diseases is es-
sential to help increase mental health awareness and
normalize attention to mental health as part of the overall
care of youth with rheumatologic diseases. Normalization
of mental health care is critical in reducing stigma and
fear, both of which have been reported by youth with SLE
and their parents as common barriers to seeking mental
health treatment [72]. Partnerships with community pro-
viders and foundations can enhance dissemination of edu-
cational information and normalize mental health issues.
For example, the National Resource Center on Lupus
sponsored by Lupus Foundation of America publishes on-
line educational information to help patients and families
recognize warning signs of mental health disorders and
find assistance for management of these disorders [85].
Increasing the availability of peer support groups and
networks also has the potential to improve mental health
education of youth with rheumatologic diseases. Specif-
ically, the iPeer2Peer Program, a novel online peer men-
toring program for adolescents with JIA developed by
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investigators in Canada, improved participants’ per-
ceived ability to manage their disease compared to con-
trols [86]. Similarly, Teens Taking Charge, an internet-
based self-management program including disease-
specific information and social support for youth with
JIA in Canada, led to higher levels of knowledge and
lower pain reports [87]. Improving support for families
of youth with rheumatologic diseases also may positively
impact patient outcomes, as higher caregiver psycho-
logical distress has been associated with worse HRQL in
patients with JIA [88, 89].
While improved mental health education for both
pediatric rheumatologists and patients and their families
is necessary, education alone is insufficient. Sustainable
systems for the delivery of mental health services must
be developed. Dedicated application of implementation
science principles and quality improvement method-
ology has been successfully utilized to improve mental
health care for youth with other chronic diseases [90].
Funding is needed to support implementation research
and quality improvement initiatives aimed at optimizing
mental health care for youth with rheumatologic dis-
eases. Required funding for overall increased mental
health resources for this population should not be over-
looked either, particularly given reported lack of time
and adequate staffing for mental health screening and
treatment in pediatric rheumatology settings [70]. The
necessity of this funding priority aligns with the goals
and expectations of our patients, as indicated in a mixed
methods study of youth with SLE showing that research
focused on alleviating poor psychological outcomes is
viewed as a top priority in this population [91].
Conclusions
The prevalence and burden of mental health disorders
in youth with rheumatologic diseases is high. The evi-
dence from pediatric and adult literature of rheumato-
logic diseases indicates that mental illness has a
pervasive impact on multiple areas of health behaviors,
disease outcomes, and quality of life. Improved identifi-
cation and early treatment of mental health disorders
may improve outcomes in this population, and pediatric
rheumatologists are well situated to provide mental
health screening and offer early intervention. Additional
training for pediatric rheumatologists is necessary to en-
able provision of effective mental health care. Potential
educational strategies include the development of clin-
ical guidelines for mental health screening within
pediatric rheumatology settings and revision of pediatric
rheumatology fellowship cuuricula to include mental
health didactics, workshops, and clinical experience in
behavioral health. Improved education of patients and
families is also essential in order to increase awareness
of and normalize inclusion of mental health as part of
overall care. Future work should focus on developing
and implementing sustainable systems for the delivery of
mental health care alongside medical care for youth with
rheumatologic diseases. Increased advocacy for mental
health resources and research funding is needed to sup-
port the above initiatives.
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